We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$29.8B
AUM Growth
+$2.61B
Cap. Flow
+$204M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.49%
Holding
319
New
30
Increased
92
Reduced
86
Closed
4

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$62.9M
2
OGN icon
Organon & Co
OGN
+$57.9M
3
MAR icon
Marriott International
MAR
+$50.4M
4
MSFT icon
Microsoft
MSFT
+$48.5M
5
NOW icon
ServiceNow
NOW
+$38.6M

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$75.9M
2
ABBV icon
AbbVie
ABBV
+$59.9M
3
AAPL icon
Apple
AAPL
+$28.9M
4
MO icon
Altria Group
MO
+$19.2M
5
MRK icon
Merck
MRK
+$13M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 20.63%
3 Consumer Staples 18.28%
4 Communication Services 11.3%
5 Healthcare 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDY icon
76
Teledyne Technologies
TDY
$30.4B
$41.8M 0.14%
99,903
NVS icon
77
Novartis
NVS
$297B
$37.8M 0.13%
414,271
-12,954
-3% -$1.15M
IT icon
78
Gartner
IT
$10.1B
$34.6M 0.12%
+142,683
New +$31.2M
CLVT icon
79
Clarivate
CLVT
$1.27B
$32.8M 0.11%
+1,193,154
New +$32.8M
LECO icon
80
Lincoln Electric
LECO
$14.3B
$30.1M 0.1%
228,700
PFE icon
81
Pfizer
PFE
$143B
$29.4M 0.1%
749,742
+45,888
+7% +$1.78M
WBA
82
DELISTED
Walgreens Boots Alliance
WBA
$28.9M 0.1%
549,931
-20,194
-4% -$1.09M
BUD icon
83
AB InBev
BUD
$167B
$26.7M 0.09%
370,421
-6,735
-2% -$491K
CHTR icon
84
Charter Communications
CHTR
$17.3B
$25.9M 0.09%
35,856
ALG icon
85
Alamo Group
ALG
$1.94B
$23.1M 0.08%
151,500
RDS.A
86
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$22.2M 0.07%
548,899
-28,479
-5% -$1.13M
PAA icon
87
Plains All American Pipeline
PAA
$17.3B
$18.9M 0.06%
1,666,927
-8,000
-0.5% -$82.2K
STZ icon
88
Constellation Brands
STZ
$22.2B
$17.1M 0.06%
72,900
-150
-0.2% -$35.2K
SBUX icon
89
Starbucks
SBUX
$120B
$16.2M 0.05%
144,613
+3,060
+2% +$346K
TTE icon
90
TotalEnergies
TTE
$195B
$14.5M 0.05%
320,551
+4,525
+1% +$212K
BABA icon
91
Alibaba
BABA
$293B
$13.8M 0.05%
61,030
+3,528
+6% +$784K
CW icon
92
Curtiss-Wright
CW
$26.7B
$13.3M 0.04%
111,684
BAC icon
93
Bank of America
BAC
$435B
$12.5M 0.04%
302,716
+18,791
+7% +$770K
ANAT
94
DELISTED
American National Group, Inc. Common Stock
ANAT
$11.1M 0.04%
74,698
DLR icon
95
Digital Realty Trust
DLR
$69.7B
$11M 0.04%
72,941
+12,670
+21% +$1.91M
T icon
96
AT&T
T
$159B
$10.6M 0.04%
488,058
+53,725
+12% +$1.22M
CSCO icon
97
Cisco
CSCO
$457B
$10.4M 0.03%
195,913
+52,786
+37% +$2.78M
KHC icon
98
Kraft Heinz
KHC
$30.7B
$9.16M 0.03%
224,697
+1,565
+0.7% +$65.9K
CARR icon
99
Carrier Global
CARR
$51B
$9.04M 0.03%
186,050
-10,757
-5% -$481K
APAM icon
100
Artisan Partners
APAM
$2.79B
$8.79M 0.03%
+173,000
New +$9.09M

Similar funds

Fayez Sarofim & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Fayez Sarofim & Co held 319 positions worth $29.8B, up 9.6% from $27.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q2 2021 filing shows 30 new, 92 increased, 86 reduced and 4 closed positions. Its largest new stake was Organon & Co: 1,758,918 shares worth $53.2M. The largest sale was Chubb, an estimated $75.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q2 2021 buy was Organon & Co: 1,758,918 shares worth $53.2M.
  • Fayez Sarofim & Co added most to Procter & Gamble in Q2 2021, an estimated $62.9M increase.
  • Fayez Sarofim & Co's biggest Q2 2021 reduction was Chubb, cutting an estimated $75.9M.
  • Fayez Sarofim & Co fully exited US Bancorp in Q2 2021, selling an estimated $359K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $29.8B portfolio in Q2 2021.
  • Fayez Sarofim & Co opened 30 new positions and closed 4 in Q2 2021.
  • Fayez Sarofim & Co's portfolio value rose 9.6% quarter-over-quarter to $29.8B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2021, filed 13 Aug 2021.